{"schema_version":"secwatch.filing_event.v1","accession":"0000055785-22-000032","form_type":"8-K","ticker":"KMB","cik":"0000055785","company_name":"KIMBERLY CLARK CORP","filed_at":"2022-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.316594+00:00","generated_at":"2026-06-26T05:29:03.133318+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Kimberly-Clark Q1 net sales $5.1B (+7%), adj EPS $1.35 (-25% YoY), raises organic sales growth guidance","bullets":["Net sales $5.1B, +7% YoY; organic sales +10% (price +6%, volume +2%, mix +2%).","Adj EPS $1.35 vs $1.80 YoY (-25%); GAAP EPS $1.55 vs $1.72.","FY2022 organic sales growth guidance raised to 4-6% from 3-4%; adj EPS outlook $5.60-$6.00.","Q1 input cost inflation $470M; full-year cost headwind raised to $1.1-1.3B (prev. $750-900M).","Segment op profit declines: Personal Care -1%, Consumer Tissue -36%, KCP -29%."],"urls":{"canonical":"https://secwatch.observer/filing/0000055785-22-000032","json":"https://secwatch.observer/filing/0000055785-22-000032.json","markdown":"https://secwatch.observer/filing/0000055785-22-000032.md","text":"https://secwatch.observer/filing/0000055785-22-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55785/000005578522000032/0000055785-22-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55785/000005578522000032/pre-20220422.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T05:29:03.133318+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}